Skip to main content
. Author manuscript; available in PMC: 2023 Jul 21.
Published in final edited form as: Am J Gastroenterol. 2022 Jul 11;117(12):1990–1998. doi: 10.14309/ajg.0000000000001901

Table 1.

Baseline characteristics at LT among first vs prior decompensation groups

Factor First decompensation n = 210 (100%) Prior decompensation N = 31 (100%) P value
Agea 43 (35, 52) 38 (36, 47) 0.23
Male 143 (68) 16 (52) 0.07
Race
 White 177 (85) 27 (87) 0.97
 African American 13 (6) 2 (6)
 Latinx 8 (4) 1 (3)
 Asian 8 (4) 1 (3)
 Other 3 (1) 0 (0)
Insurance
 Private 138 (66) 22 (71) 0.73
 Medicare 14 (7) 1 (3)
 Medicaid 56 (27) 8 (26)
Body mass indexa 29 (25–34) 31 (25–38) 0.16
Sodiuma 136 (133, 140) 138 (134, 141) 0.42
INRa 2.2 (1.9, 2.8) 2.4 (2.1, 2.9) 0.35
Bilirubina 26 (16, 35) 26 (19, 34) 0.78
Creatininea 2.3 (1.4, 3.9) 1.7 (1.5, 2.8) 0.28
Renalreplacement therapy 121 (58) 20 (67) 0.35
MELD-Na Scorea 39 (35, 40) 39 (36, 40) 0.98
On ventilator 33 (17) 9 (30) 0.08
Overt hepatic encephalopathy 100 (50) 13 (43) 0.46
Days of abstinencea 45 (25, 73) 52 (25, 109) 0.09
Married or significant other 134 (64) 23 (74) 0.51
History of psychiatric disease 99 (47) 17 (57) 0.33
Current smoker 42 (21) 9 (31) 0.23
Current marijuana 18 (9) 4 (13) 0.47
History of illicit drug use 28 (14) 5 (17) 0.65
History of failed rehab attempts
 No priors 146 (71) 16 (53) <0.001
 1 prior 47 (23) 6 (20)
 Multiple 12 (6) 8 (27)
Family history of alcohol use disorder
 None 113 (56) 13 (46) 0.51
 Extended family 24 (12) 3 (11)
 Immediate family 64 (32) 12 (43)
Employment immediately before presentation 114 (54) 13 (42) 0.20
Legal history (e.g., DUI and custody loss because of alcohol)
 None 167 (80) 22 (73) 0.21
 1 prior 26 (12) 3 (10)
 Multiple 15 (7) 5 (17)
Alcoholunits perdaya 12 (7, 18) 9 (6, 14) 0.03
Years of heavy drinking 12 (6, 20) 11 (7, 20) 0.79
Meets NIAAA criteria for AH 174 (83) 26 (87) 0.60
Follow-up time in yearsa 2.3 (1.1, 4.0) 1.7 (0.6, 2.9) 0.08

AH, alcohol-associated hepatitis; INR, international normalized ratio; IQR, interquartile range; MELD-Na, Model for End-Stage Liver Disease-Sodium score; NIAAA, National Institute on Alcohol Abuse and Alcoholism.

a

Median (IQR).